Expert insights. Personalized for you.
Biotechnology Related Topics 
McKinsey
JUNE 9, 2022
Emerging biotechnology companies are less satisfied than large pharmaceutical companies with their contract research organizations (CROs). Insights on Life Sciences Biotechnology
McKinsey
JUNE 10, 2022
Insights on Life Sciences BiotechnologyFrom 2019 to 2021, venture capitalists plowed $35 billion into biotech companies with advanced platform technologies that could transform the industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
McKinsey
APRIL 8, 2022
Insights on Life Sciences Biotechnology InnovationHarnessing advances in science and technology can deliver transformative therapies faster while reducing the socioeconomic burden of disease.
McKinsey
MAY 31, 2022
Insights on Life Sciences Pharmaceuticals Biotechnology Artificial IntelligenceBiopharma companies’ pipelines are full of assets they source externally to access innovation. Four practices will help ensure their investments flourish at a time of fierce competition.
McKinsey
MAY 11, 2022
Insights on Life Sciences Health Care BiotechnologyBiotech stocks have taken a hit, but the sector will probably rebound. Companies can navigate the downturn by scrutinizing cash management and financing and rethinking paths to long-term value creation.
McKinsey
MARCH 23, 2022
Insights on Life Sciences Biotechnology Globalization StrategyEstablishing an international presence with a first launch is a challenge, but learning from others’ experiences can help biotechs avoid missteps and maximize their chances of success.
McKinsey
MAY 17, 2021
Insights on Pharmaceuticals & Medical Products Pharmaceuticals BiotechnologyViral-vector gene therapies show great promise, but the full extent of their clinical impact in the long term is not yet certain. Success depends on innovative solutions that remain under development.
McKinsey
MAY 12, 2021
Insights on Pharmaceuticals & Medical Products BiotechnologyThe leaders of Gingko Bioworks and the BIO organization discuss the future of biological technologies, from developing vaccines faster to changing how we produce food.
McKinsey
JUNE 7, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology PharmaceuticalsWith rising US adoption, biosimilars are gathering even more momentum. Successful companies will innovate their commercial models, rethink their portfolio management, and accelerate their R&D.
McKinsey
APRIL 30, 2021
Insights on Pharmaceuticals & Medical Products Venture capital BiotechnologyEven in tough times, investor expectations and deal making in biotech are surging. Can the sector maintain its strong growth?
McKinsey
MAY 13, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology Pharmaceuticals Oncology/CancerThe small number of people with rare diseases raises challenges for the development and launch of all therapies for such conditions, but rare cancers face extra barriers to widespread treatment.
Frost & Sullivan
MARCH 30, 2021
Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6
Frost & Sullivan
JULY 22, 2021
Healthcare News Press Releases biopharma biopharmaceutical biotechnology biotherapeutics COVID-19 vaccine logistics DNA drug mrna pharma Pharmaceutical research RNA therapeutics vaccine
McKinsey
JULY 29, 2021
Insights on Pharmaceuticals & Medical Products BiotechnologyWe mapped out 1,382 biotechs based in Europe and some interesting themes emerged.
Frost & Sullivan
MARCH 30, 2021
Pharmaceuticals and biotechnology, IVD, advanced medical technologies, medical imaging and informatics, and digital health expected to hit over $2.6
McKinsey
AUGUST 5, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology EuropeEurope is a powerhouse in scientific publishing with roughly twice the output of the United States and three times that of China.
McKinsey
AUGUST 26, 2021
Insights on Pharmaceuticals & Medical Products BiotechnologyHow can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas.
McKinsey
AUGUST 23, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology EuropeEurope’s biotech sector has made meaningful progress in attracting capital. However, raising more capital will be essential to the continued growth of this sector.
McKinsey
SEPTEMBER 15, 2021
Insights on Life Sciences BiotechnologyHow can biotechs and investors succeed in the future? To scale up innovation, industry stakeholders need to focus on several key areas.
McKinsey
AUGUST 23, 2021
Insights on Pharmaceuticals & Medical Products Biotechnology EuropeEurope may be catching up with the United States in biotech innovation and funding. Its overall score on the Biotech Innovation Index improved by 20 percent in 2015–17 and 2018–20.
LaVoie Health Science Blog
JANUARY 26, 2021
The “ 2021 Preview: A 360 Degree Global Market View, ” virtual webinar was designed to discuss global market trends on public and private United States, Europe, and China markets, JPM virtual week in January 2021, and more.
Frost & Sullivan
JUNE 21, 2022
DSM has a strong portfolio of bio-based ingredients that will be complemented by Firmenich’s long-standing experience in natural and biotechnology-derived ingredients. In May 2022, DSM and Firmenich announced their plans to merge together.
Frost & Sullivan
JUNE 21, 2022
DSM has a strong portfolio of bio-based ingredients that will be complemented by Firmenich’s long-standing experience in natural and biotechnology-derived ingredients. In May 2022, DSM and Firmenich announced their plans to merge together.
LaVoie Health Science Blog
JANUARY 7, 2021
In addition to expanding its strategic communications team, LHS also debuted its virtual webinar series with Biotechnology Innovation Organization, including a 2021 Preview: A 360-Degree Global Market View. BOSTON & NEW YORK – January 7, 2021.
LaVoie Health Science Blog
OCTOBER 5, 2020
Successful candidate will be a detail-oriented self-starter with 3-5 years of agency or related experience in healthcare in particular for biotechnology and pharmaceutical industries or technology. Join a health science focused integrated communications agency and be part of the agency’s second phase of growth. Strong detail oriented public relations/communications professional needed for growing life science/biopharmaceutical practice.
LaVoie Health Science Blog
NOVEMBER 16, 2021
Further Strengthens IR Leadership Team and Supports Integrated Strategic Communications Capabilities and Continued Business Growth. link].
LaVoie Health Science Blog
AUGUST 4, 2020
BOSTON AND NEW YORK – AUGUST 03, 2020. LaVoieHealthScience (LHS), an integrated investor and public relations consulting agency focused on advancing health and science innovations, today announced that Donna L.
LaVoie Health Science Blog
JULY 16, 2021
Interviews with our senior practice managers about issues of important to life science innovators.
BTD Consulting
DECEMBER 28, 2020
From pharmaceuticals & biotechnology to software & hardware to banking to oil & gas, alliances and JVs have reshaped competition. Create value. Increase value. Build or buy or borrow. Your menu. Most successful companies partake of all three.
Agorize
JUNE 28, 2021
Beauty is in the eye of the beholder, but there is less debate regarding the rapid growth of the beauty and cosmetics industry. Combined with fields of deep tech, the future of beauty is not only more sustainable, environmentally friendly, but also scalable and innovative.
Partnership on AI
MAY 15, 2019
The Transformations of the Human program at the Berggruen Institute is designed as a philosophical study and artistic exploration of the manifold ways in which artificial intelligence and biotechnology challenge our established conceptions of what it means to be human. Central to our ability to produce unique research is the diversity of our “community of practice.”
Frost & Sullivan
SEPTEMBER 21, 2021
Since then, the company expanded its business with fermentation and biotechnology as its core technologies, and entered the pharmaceutical business in the 1980s, all of which continue to be global growth centers. SANTA CLARA, Calif.
TIM Review
FEBRUARY 27, 2021
The term “bioeconomy” covers multiple scientific fields and interrelated perspectives highlighting biotechnology, bio-resources, and bio-ecology (Bugge et al., If we don't change, we don't grow. . Gail Sheehy. Introduction .
TIM Review
JUNE 28, 2021
An example of this can be found in the Nobel Laureate, Michael Smith, of the University of British Columbia, who established a then-new interdisciplinary institute, the UBC Biotechnology Laboratory in 1986. " Cross Pollinators can create something new and better through the unexpected juxtaposition of seemingly unrelated ideas or concepts.". Tom Kelley Author of Creative Confidence, The Art of Innovation and The Ten Faces of Innovation.
TIM Review
OCTOBER 30, 2020
Health Care : Equipment and services, pharmaceuticals, biotechnology, life science. "A powerful idea communicates some of its strength to him [or her ] who challenges it.”. Marcel Proust.
TIM Review
OCTOBER 30, 2020
Sustainability communications can bring your business many benefits, and help you stand out from your competitors. Amfori. A guide to effective sustainability communications . Introduction. Sustainability concerns have become a major driver of business change (Seebode et al.,
87 
Let's personalize your content